Founder, Gilt Groupe
Vice president, chief strategy and operating officer of the Texas Medical Center
Managing Director, D.E. Shaw and Co., L.P.
Founder and Managing Director of DEV
Co-Founder, Sakti3
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
CEO and co-founder of BoostSuite
Partner at New Enterprise Associates
The transformation of Johnson Controls International continues.
On Tuesday, the company said it reached a deal to sell its power solutions business, which makes a variety of vehicle batteries, in a cash transaction valued at $13.2 billion. The buyers are investment... Read more »
GreatCall, the maker of the Jitterbug cellphone and other products and services for older adults, has extended its partnership with the San Francisco-based ride-hailing company Lyft to offer GreatCall customers the ability to schedule rides without a smartphone app. No financial... Read more »
[Updated 11/13/18, 12:05 pm, with executive comments throughout.] The data storage wars rage on.
Boston-based primary data storage and backup provider ClearSky Data has raised $20 million in new funding to bring more customers aboard its “on-demand” hybrid cloud... Read more »
Cells have a built-in way of breaking down damaged or unneeded proteins. Kymera Therapeutics is trying to harness this process as a therapy—using it to get rid of disease-causing proteins. As the biotech prepares to test its technology in humans, it... Read more »
Most drugs target proteins in the cell, but the world of RNA has remained largely untapped by companies making chemical-based, or small-molecule drugs. That’s changing though—just in the last couple of years, there’s been a mini-boom in biotechs trying to overturn... Read more »
A little more than a month after Rethink Robotics shut down, a competitor has hired more than 20 of the Boston-based firm’s former employees.
Universal Robots, a Denmark-based maker of collaborative industrial robots, announced Tuesday it has brought on key... Read more »
Houston—Commercial drones are equipped with some of the latest innovations in cameras, sensors, and analytics, so Scott Parazynski wondered why pilots are still using outmoded controllers.
“We’ve grown accustomed to these tools but decades later it’s the same [controller] model,”... Read more »
Apptio is being taken private by investment firm Vista Equity Partners in a $1.94 billion acquisition.
Founded in Bellevue, WA, in 2007, Apptio (NASDAQ: APTI) helps corporate leaders track and manage IT spending. The company went public in 2016 with... Read more »
Nuance Communications is selling its document imaging division to Kofax for $400 million in cash, as Nuance’s new CEO narrows the company’s focus on its conversational artificial intelligence products and cloud-related technologies.
Nuance’s (NASDAQ: NUAN) document imaging business provides enterprise... Read more »
It’s hard to say no to $8 billion. Qualtrics, the enterprise software firm that was on the verge of going public, has pulled its IPO in favor of selling to German software giant SAP for $8 billion in cash.
Qualtrics—which has... Read more »
[Updated 11/12/18, 10:31 am, with deal terms.] Athenahealth has reached an agreement to be bought for approximately $5.7 billion in cash by private equity firms Veritas Capital and Evergreen Coast Capital, an affiliate of activist hedge fund Elliott Management.... Read more »
When Chris Meyer was enveloped by a ball of fire in a construction accident and rushed to a Madison, WI, hospital 14 months ago, his loved ones and friends feared for his life. They also worried about the future of Sector67,... Read more »
Two months ago, the medical community was all abuzz over a big clinical study that showed a prescription fish-oil supplement could reduce the risk of heart disease. Today, a fuller look at the data presents a more nuanced picture.
Doctors working... Read more »
A 10-person team of researchers at the Salk Institute for Biological Studies has been awarded an eight-year, $19.2 million grant to investigate mechanisms underlying Alzheimer’s disease and aging-related cognitive decline and uncover new therapies.
The grant, announced Friday by the research... Read more »
One of the biggest gambles in biotech history is about to be tested on Wall Street.
Moderna, the high-flying yet secretive developer of messenger RNA therapeutics, filed papers on Friday afternoon outlining its long-awaited IPO. In its prospectus, Moderna set an... Read more »
Acquisitions, partnerships, and an FDA approval mark this week’s roundup in Boston technology news. Read on for more:
—Boston University is adding artificial intelligence education to its electrical and computer engineering courses through a partnership with Boston A.I. company Neurala, to... Read more »
The humble cell has been getting a lot of attention in the medical world lately, and Ann Arbor, MI-based biotech startup Celsee wants to make it easier to study them.
As precision medicine and genomic analysis become more sophisticated, clinicians are... Read more »
There was plenty at stake in this week’s midterm elections, and not just in terms of political wins and losses. With congress now divided—Democrats took back control of the House and Republicans extended their majority in the Senate—the implications are significant... Read more »
It’s been a busy week for Wisconsin’s innovation community, with entrepreneurship events taking place statewide for Startup Wisconsin Week (check out highlights on Twitter). Here are some of the other headlines from the past week:
—Wauwatosa-based Froedtert Health, which runs... Read more »
Each new technology has a story behind it. On Dec. 5, our Xchange Forum will offer a behind-the-scenes look at how some of them aim to transform healthcare.
Xconomy’s San Francisco Biotech: The Next Generation, will feature three Bay Area... Read more »
Former Google CEO Eric Schmidt says the next five years of artificial intelligence and machine learning will be more like Apple’s Siri and Amazon’s Alexa than a self-driving sedan or a robo-surgeon taking out your appendix.
“There are still significant errors,... Read more »
All-seeing orbs, a distant planet and source of a life-giving drug, interstellar faster-than-light space travel, a carbon-freezing technique used to lock away enemies.
The science fiction and fantasy creations—carbonite, palantir, Arrakis, warp drive—evoke the sort of futuristic vision that many startups... Read more »
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Founder and CEO of Brooks Bell Inc.
CEO, FullContact
Managing director, the Foundry Group
Nobel Laureate, Professor of Biology, Caltech
Co-Founder and CEO, DNAnexus
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
